A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.
Jamieson, C., Basten, S., Campbell, R.A., Cumming, I.A., Gillen, K.J., Gillespie, J., Kazemier, B., Kiczun, M., Lamont, Y., Lyons, A.J., Maclean, J.K., Moir, E.M., Morrow, J.A., Papakosta, M., Rankovic, Z., Smith, L.(2010) Bioorg Med Chem Lett 20: 5753-5756
- PubMed: 20805031 
- DOI: https://doi.org/10.1016/j.bmcl.2010.07.138
- Primary Citation of Related Structures:  
3O28, 3O29, 3O2A - PubMed Abstract: 
Starting from an HTS derived hit 1, application of biostructural data facilitated rapid optimization to lead 22, a novel AMPA receptor modulator. This is the first demonstration of how structure based drug design can be exploited in an optimization program for a glutamate receptor.
Organizational Affiliation: 
Merck Research Laboratories, MSD, Motherwell, Lanarkshire ML1 5SH, UK.